Abstract
Background: Adipose-derived stem cells secrete various cytokines that promote hair growth.
Objective: To describe our experience of hair regeneration therapy using adipose-derived stem cellconditioned medium.
Results: We performed the hair regeneration therapy in numerous Japanese patients and reported good results. We described characteristics of the commercialized conditioned medium, treatment methods, and future directions.
Conclusion: Treatment using adipose-derived stem cell-conditioned medium is highly effective and may represent a new therapy for alopecia.
Keywords: Alopecia, adipose-derived stem cells, conditioned medium, cytokines, trichogram, half-side comparison study.
Current Stem Cell Research & Therapy
Title:Hair Regeneration Therapy: Application of Adipose-Derived Stem Cells
Volume: 12 Issue: 7
Author(s): Hirotaro Fukuoka*, Keigo Narita and Hirotaka Suga
Affiliation:
- Cherry-Blossom Plastic and Regenerative Surgery, 1-4-10 Nishi Shinjuku, Shinjuku-ku, Tokyo 160-0023,Japan
Keywords: Alopecia, adipose-derived stem cells, conditioned medium, cytokines, trichogram, half-side comparison study.
Abstract: Background: Adipose-derived stem cells secrete various cytokines that promote hair growth.
Objective: To describe our experience of hair regeneration therapy using adipose-derived stem cellconditioned medium.
Results: We performed the hair regeneration therapy in numerous Japanese patients and reported good results. We described characteristics of the commercialized conditioned medium, treatment methods, and future directions.
Conclusion: Treatment using adipose-derived stem cell-conditioned medium is highly effective and may represent a new therapy for alopecia.
Export Options
About this article
Cite this article as:
Fukuoka Hirotaro*, Narita Keigo and Suga Hirotaka, Hair Regeneration Therapy: Application of Adipose-Derived Stem Cells, Current Stem Cell Research & Therapy 2017; 12 (7) . https://dx.doi.org/10.2174/1574888X12666170522114307
DOI https://dx.doi.org/10.2174/1574888X12666170522114307 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bupropion in the Depression-Related Sexual Dysfunction: A Systematic Review
CNS & Neurological Disorders - Drug Targets Overlooked Issues of Snakebite Management: Time for Strategic Approach
Current Topics in Medicinal Chemistry Acute Cardioembolic Cerebral Infarction: Answers to Clinical Questions
Current Cardiology Reviews Medicinal Plants with Multiple Effects on Cardiovascular Diseases: A Systematic Review
Current Pharmaceutical Design Anti-Inflammatory and Anti-Allergy Drugs in Rhinosinusitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Current Neuropharmacology Update in Glaucoma Medicinal Chemistry: Emerging Evidence for the Importance of Melatonin Analogues
Current Medicinal Chemistry Dystonia Associated with Lamotrigine Therapy: A Case Report and Review of the Literature
Current Drug Safety Disulfiram: An Old Therapeutic with New Applications
CNS & Neurological Disorders - Drug Targets Lithium and Kidney, 60 Years Later
Current Drug Safety Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery GHB, GBL and 1,4-BD Addiction
Current Pharmaceutical Design Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis
Current Drug Targets - Inflammation & Allergy Aquaretic Agents: Whats Beyond the Treatment of Hyponatremia?
Current Pharmaceutical Design Unusual Cerebral Involvement of Rheumatoid Arthritis Mimicking a Tumor
Current Medical Imaging Platelets and Vascular Risk: An Option for Treatment
Current Pharmaceutical Design Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts
Current Drug Safety Role of Beta2 Agonists in Respiratory Medicine with Particular Attention to Novel Patents and Effects on Endocrine System and Immune Response
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials